Ligand validation:8J32

V2M: N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide

V2M is a Ligand Of Interest in 8J32 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8J32_V2M_B_401	34%	5%	0.165	0.846	2.79	2.41	6	9	1	0	100%	1
8J32_V2M_A_401	27%	6%	0.196	0.842	2.79	2.4	6	9	0	0	100%	1
6XHL_V2M_A_9001	93%	17%	0.069	0.962	1.77	1.8	3	4	0	0	100%	1
6XHM_V2M_B_9001	81%	71%	0.085	0.935	0.54	0.56	-	-	0	0	100%	1
8J35_V2M_B_401	80%	5%	0.086	0.934	2.86	2.35	6	8	0	0	100%	1
8J3A_V2M_B_401	73%	32%	0.102	0.929	1.6	1.1	2	5	1	0	100%	1
8J37_V2M_B_401	73%	30%	0.094	0.919	1.61	1.19	1	6	0	0	100%	1
8DSU_V2M_B_504	70%	1%	0.102	0.918	5.7	1.85	17	11	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.